DGLYX
Price
$23.13
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
RNPCX
Price
$63.12
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
Ad is loading...

DGLYX vs RNPCX

Header iconDGLYX vs RNPCX Comparison
Open Charts DGLYX vs RNPCXBanner chart's image
BNY Mellon Global Stock - Y
Price$23.13
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
American Funds New Perspective R3
Price$63.12
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
DGLYX vs RNPCX Comparison Chart
Loading...
VS
DGLYX vs. RNPCX commentary
Sep 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGLYX is a StrongBuy and RNPCX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RNPCX has more cash in the bank: 142B vs. DGLYX (996M). RNPCX pays higher dividends than DGLYX: RNPCX (0.58) vs DGLYX (0.39). DGLYX was incepted earlier than RNPCX: DGLYX (11 years) vs RNPCX (22 years). RNPCX is a more actively managed with annual turnover of: 17.00 vs. DGLYX (10.12). RNPCX has a lower initial minimum investment than DGLYX: RNPCX (250) vs DGLYX (1000000). RNPCX annual gain was more profitable for investors over the last year : 17.69 vs. DGLYX (-0.18). RNPCX return over 5 years is better than : 41.92 vs. DGLYX (2.88).
DGLYXRNPCXDGLYX / RNPCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years22 years-
Gain YTD9.07814.19964%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets996M142B1%
Annual Yield % from dividends0.390.5867%
Returns for 1 year-0.1817.69-1%
Returns for 3 years-22.88-7.48306%
Returns for 5 years2.8841.927%
Returns for 10 years20.6963.0233%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SFST33.540.04
+0.12%
Southern First Bancshares
ZBH106.280.04
+0.04%
Zimmer Biomet Holdings
RELY14.22-0.05
-0.35%
Remitly Global
AUPH7.08-0.06
-0.84%
Aurinia Pharmaceuticals
ITRM1.09-0.01
-0.91%
Iterum Therapeutics plc